Pesquisas alternativas:
films company » film company (Expandir a Pesquisa), skills company (Expandir a Pesquisa), his company (Expandir a Pesquisa)
tail complex » oil complex (Expandir a Pesquisa), atrial complex (Expandir a Pesquisa), basal complex (Expandir a Pesquisa)
complex can » complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa), complex cell (Expandir a Pesquisa)
all powers » small powers (Expandir a Pesquisa), alex powers (Expandir a Pesquisa), half powers (Expandir a Pesquisa)
powers d » powers _ (Expandir a Pesquisa), powers j (Expandir a Pesquisa)
d newly » do newly (Expandir a Pesquisa), de newly (Expandir a Pesquisa), _ newly (Expandir a Pesquisa)
can now » can non (Expandir a Pesquisa), can new (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
5 tail » _ tail (Expandir a Pesquisa), a tail (Expandir a Pesquisa), c tail (Expandir a Pesquisa)
j all » _ all (Expandir a Pesquisa), b all (Expandir a Pesquisa), j ali (Expandir a Pesquisa)
films company » film company (Expandir a Pesquisa), skills company (Expandir a Pesquisa), his company (Expandir a Pesquisa)
tail complex » oil complex (Expandir a Pesquisa), atrial complex (Expandir a Pesquisa), basal complex (Expandir a Pesquisa)
complex can » complex case (Expandir a Pesquisa), complex care (Expandir a Pesquisa), complex cell (Expandir a Pesquisa)
all powers » small powers (Expandir a Pesquisa), alex powers (Expandir a Pesquisa), half powers (Expandir a Pesquisa)
powers d » powers _ (Expandir a Pesquisa), powers j (Expandir a Pesquisa)
d newly » do newly (Expandir a Pesquisa), de newly (Expandir a Pesquisa), _ newly (Expandir a Pesquisa)
can now » can non (Expandir a Pesquisa), can new (Expandir a Pesquisa), can ngoc (Expandir a Pesquisa)
5 tail » _ tail (Expandir a Pesquisa), a tail (Expandir a Pesquisa), c tail (Expandir a Pesquisa)
j all » _ all (Expandir a Pesquisa), b all (Expandir a Pesquisa), j ali (Expandir a Pesquisa)
1
Por Blitvich, Bradley J., Beaty, Barry J., Blair, Carol D., Brault, Aaron C., Dobler, Gerhard, Drebot, Michael A., Haddow, Andrew D., Kramer, Laura D., LaBeaud, Angelle Desiree, Monath, Thomas P., Mossel, Eric C., Plante, Kenneth, Powers, Ann M., Tesh, Robert B., Turell, Michael J., Vasilakis, Nikos, Weaver, Scott C.
Publicado no Am J Trop Med Hyg (2018)
“... and necessary because of the need to accommodate newly discovered and unclassified viruses, other changes are a...”Publicado no Am J Trop Med Hyg (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Weller, M., Butowski, N. A., Tran, D. D., Recht, L. D., O’Rourke, D. M., Finocchiaro, G., Perry, J. R., Wick, W., Stupp, R., Sampson, J. H.
Publicado no Neuro Oncol (2017)
“...). In three phase 2 studies of 105 total patients with newly diagnosed, EGFRvIII+ GBM and minimal residual...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
3
“... for optimizing the design of DBT detectors. Methods: A quantum-limited system and 20 keV x-rays are considered...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... and to compare performance of two newly developed TRAb assays (third-generation thyrotropin-binding inhibitor...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“...The Enhancer of split complex [E(spl)-C] in Drosophila encompasses a variety of functional elements...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“...Dermal dendritic cells from eleven cases of mycosis fungoides (MF) (six patch and five plaque stage...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Jenkinson, M. D., Javadpour, M., Haylock, B. J., Young, B., Bulbeck, H., Farrell, M., Preusser, M., Hughes, D., Gamble, C., Weber, D.
Publicado no Neuro Oncol (2017)
“...Introduction: Atypical meningioma are very rare tumours with a recurrence rate of 30-58% at 5-years...”Publicado no Neuro Oncol (2017)
Obter o texto integral
Obter o texto integral
Artigo
8
Por E.O.B. Ogedengbe, P.A. Aderoju, D.C. Nkwaze, J.B. Aruwajoye, M.B. Shitta
Publicado em 2019-11-01
“... appliances. Using a newly-developed renewable energy (RE) calculator, standard energy performance...”Publicado em 2019-11-01
Obter o texto integral
Artigo
9
Por Ballinger, Tarah J., Reddy, Anurag, Althouse, Sandra K., Nelson, Emily M., Miller, Kathy D., Sledge, Jeffrey S.
Publicado no Breast Cancer Res Treat (2018)
“... intervention strategies. METHODS: Patients with newly diagnosed stage 0–III breast cancer were enrolled...”Publicado no Breast Cancer Res Treat (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Diaz, Maureen H., Desai, Heta P., Morrison, Shatavia S., Benitez, Alvaro J., Wolff, Bernard J., Caravas, Jason, Read, Timothy D., Dean, Deborah, Winchell, Jonas M.
Publicado no PLoS One (2017)
“... genome sequencing (WGS) analysis of 107 M. pneumoniae isolates, including 67 newly sequenced using...”Publicado no PLoS One (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Sarkar, Mohosin, Pascal, Bruce D., Steckler, Caitlin, Aquino, Claudio, Micalizio, Glenn C., Kodadek, Thomas, Chalmers, Michael J.
Publicado no J Am Soc Mass Spectrom (2013)
“... users to generate libraries in silico. The user can then search all possible members of the chemical...”Publicado no J Am Soc Mass Spectrom (2013)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Islim, A I, Mohan, M, Moon, R, Kolamunnage-Dona, R, Rathi, N, Mills, S J, Brodbelt, A R, Jenkinson, M D
Publicado no Neuro Oncol (2018)
“.... Rates of active monitoring failure at 5-years were 3%, 28% and 75% respectively. After 5-years of follow...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
13
Por L. F. White, L. F. White, K. T. Tait, K. T. Tait, S. L. Kamo, S. L. Kamo, D. E. Moser, J. R. Darling
Publicado em 2020-07-01
“...<p>Baddeleyite is a powerful chronometer of mafic magmatic and
meteorite impact processes. Precise...”Publicado em 2020-07-01
Obter o texto integral
Artigo
14
Por Southey, M C, Ramus, S J, Dowty, J G, Smith, L D, Tesoriero, A A, Wong, E E M, Dite, G S, Jenkins, M A, Byrnes, G B, Winship, I, Phillips, K-A, Giles, G G, Hopper, J L
Publicado em 2011
“... high-powered field (P=0.0003); and 2.7 (1.3–5.9) for each first-degree relative with breast cancer...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Thomas, James W., Prasad, Arjun B., Summers, Tyrone J., Lee-Lin, Shih-Queen, Maduro, Valerie V.B., Idol, Jacquelyn R., Ryan, Joseph F., Thomas, Pamela J., McDowell, Jennifer C., Green, Eric D.
Publicado em 2002
“... is particularly powerful for inferring genome function and is based on the simple premise that conserved sequences...”Publicado em 2002
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Jackson, Graham H, Davies, Faith E, Pawlyn, Charlotte, Cairns, David A, Striha, Alina, Collett, Corinne, Hockaday, Anna, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi, Kamaraj, Lindsay, Jindriska, Jenner, Matthew W, Cook, Gordon, Russell, Nigel H, Kaiser, Martin F, Drayson, Mark T, Owen, Roger G, Gregory, Walter M, Morgan, Gareth J
Publicado no Lancet Oncol (2019)
“...: The Myeloma XI trial was an open-label, randomised, phase 3, adaptive design trial with three randomisation...”Publicado no Lancet Oncol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
“... of the standard EQ-5D three-level system (3L) and a newly developed, experimental five-level version (5L) using a...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Hillman, Michael A., Wilke, Russell A., Yale, Steven H., Vidaillet, Humberto J., Caldwell, Michael D., Glurich, Ingrid, Berg, Richard L., Schmelzer, John, Burmester, James K.
Publicado em 2005
“... rates. Results: Forty-three of 117 patients had no prior warfarin treatment and were eligible. Five...”Publicado em 2005
Obter o texto integral
Obter o texto integral
Artigo
19
Por Bagnarelli, P, Valenza, A, Menzo, S, Sampaolesi, R, Varaldo, P E, Butini, L, Montroni, M, Perno, C F, Aquaro, S, Mathez, D, Leibowitch, J, Balotta, C, Clementi, M
Publicado em 1996
“... (PBMCs), monocytes/macrophages cells, and the A3.01 T-lymphocyte-derived cell line was studied; both...”Publicado em 1996
Obter o texto integral
Obter o texto integral
Artigo
20
Por Oza, Amit M, Cook, Adrian D, Pfisterer, Jacobus, Embleton, Andrew, Ledermann, Jonathan A, Pujade-Lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Park-Simon, Tjoung-Won, Rustin, Gordon, Joly, Florence, Mirza, Mansoor R, Plante, Marie, Quinn, Michael, Poveda, Andrés, Jayson, Gordon C, Stark, Dan, Swart, Ann Marie, Farrelly, Laura, Kaplan, Richard, Parmar, Mahesh K B, Perren, Timothy J
Publicado no Lancet Oncol (2015)
“... ratio to standard chemotherapy (six 3-weekly cycles of intravenous carboplatin [AUC 5 or 6...”Publicado no Lancet Oncol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo